Pharma company Mangalam Drugs & Organics' stock rallied on Monday as the company announced its second quarter results for the financial year 2018.
In an otherwise lacklustre trading session, private banks rallied on Monday. Yes Bank, IndusInd Bank and Kotak Bank were trading higher.
Pharma company Biocon shot up by over 6 per cent in early trade on Monday as the company received the EIR from the USFDA.
The sector is reaping benefits of GST regime now, as we can observe from the earnings. GST implementation has changed the industry aspects and tax structure which aided the overall growth of the companies.
The Indian brand business of Strides Shasun is acquired by Eris Lifesciences for a cash consideration of Rs 500 crore. The company informed the stock exchanges through a filing on Monday.
Following stocks are close to their 52-week low as at 12.25 p.m. on November 20.
The markets on November 20 opened up. BSE Sensex is trading at 33,349.14, up by 6.34 points and the Nifty is trading at 10,283.20, down by 0.40 points.
Pharma major, Glenmark Pharmaceuticals received the final nod of USFDA for Hailey 24 Fe. The stock of the company surged by over 2 per cent in the intraday trade on Monday.
Pharma major, Cipla has announced that it has received final ANDA approval for decitabine injection 50 mg vial from the USFDA.
Overall volumes in futures & options currently stand at 62.03 lakh contracts with a turnover of Rs. 5,33,783.20 crore.
Get the post-market reports and breakfast news right in your inbox. See latest »